When tumor cells are exposed to TNF-alpha, the survival pathway is enhanced by boosting NF-kB targets and pro-growth cytokines, leading to accelerated in vivo expansion, indicating that receptor-proximal bias is prioritized over transcriptional reinforcement (Cai et al., 2017[6]). This evidence concerns the gene NFKB1 and neoplasm.